« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 120, Issue 5
, Pages 1043-1050
, November 2007
Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma
| Title | About | Type | File Size |
|---|---|---|---|
| Online Repository |
|
0 MB |
Please note that add-on components may require plug-in applications.
Supported by AstraZeneca LP.
Disclosure of potential conflict of interest: S. J. Szefler has consulting arrangements with AstraZeneca, GlaxoSmithKline, Aventis, Genentech, and Merck and has received grant support from the National Institutes of Health, the National Heart, Lung, and Blood Institute, the National Institute of Allergy and Infectious Diseases, and Ross Pharmaceuticals. J. W. Baker has received grant support from GlaxoSmithKline, AstraZeneca, Apieron, NIOXX, Sanofi-Aventis, Amgen, ALK, Altana, MedPointe, Centocor, IVAX, JNJ, and Wyeth and is on the speakers' bureau for AstraZeneca, Novartis, and Merck. T. Uryniak, M. Goldman, and P. E. Silkoff own stock in and are employed by AstraZeneca.
PII: S0091-6749(07)01726-5
doi: 10.1016/j.jaci.2007.08.063
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 120, Issue 5
, Pages 1043-1050
, November 2007
